Answers are grounded in this paper and cite their sources.
Gluten-free diets (GFDs) are widely adopted for gastrointestinal complaints, yet evidence from well-controlled gluten challenge studies supporting gluten-specific symptom generation outside coeliac disease is inconsistent. Across trials, reproducible gluten-specific effects largely disappear once fermentable carbohydrates (FODMAPs) and expectation biases are controlled for, and meta-analyses report only modest, inconsistent symptom relief. Large nocebo responses and methodological heterogeneity undermine confidence in the construct of "non-coeliac gluten sensitivity". Re-interpreting gluten-attributed symptoms through the paradigm of disorders of gut-brain interaction provides a clinically coherent framework that integrates visceral hypersensitivity, cognitive-affective processes and sociocultural drivers. This review synthesises mechanistic and clinical data, distils methodological lessons and offers practical guidance on when, and how, to consider gluten restriction. A GFD should be a last resort, time-limited probe, supervised by a dietitian, and embedded within multidisciplinary care focused on individual symptom mechanisms.
No takes yet. Share an insight, caveat, or question.
Jessica R. Biesiekierski (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: